Is LRCX stock a buy right now?

Buying LRCX depends on your goals and timeline; we do not make that call for anyone. We can lay out the evidence investors usually weigh. Of 41 Wall Street analysts covering LRCX, 35 rate it a buy, 6 a hold and 0 a sell — a consensus of Buy.

Below, we look at where the stock trades today. We also cover what Wall Street analysts think, how valuation compares with similar companies and what insiders have done with their own shares.

The chart below tracks LRCX's daily closing price from April 27, 2026 to Oct. 21, 2026. Over that stretch it is up 0.7%, from $259.01 to $260.81, with a high of $432.87 on June 30, 2026 and a low of $248.31 on April 29, 2026. Each red circle marks a week in which company insiders sold shares on the open market (8 weeks in this period; bigger circles mean more money). There are no green diamonds: no insider bought on the open market in this window.

Where LRCX trades today

$260.81 at the Oct. 21, 2026 close: 39.7% from the 52-week high of $432.87 and 87.7% above the 52-week low of $138.95. One month: -16.0%; three months: -18.4%.

What analysts say about LRCX

Of 41 Wall Street analysts covering LRCX, 35 rate it a buy, 6 a hold and 0 a sell — a consensus of Buy. Ratings changed little over three months.

LRCX valuation in one line

LRCX trades at a P/E of 45.3, 14.05× sales, revenue +26.0% year over year (latest quarter Jun 2026).

Also worth knowing about LRCX

Live LRCX data, updated every 30 minutes: LRCX insider trades, ownership and filings →

In Lam Research Corp's own words

“With AI driving higher semiconductor demand and greater device complexity, our focus on operational execution helped Lam deliver record revenue, profit, and earnings per share in the September quarter”

— Tim Archer, Lam Research's President and Chief Executive Officer · SEC filing

From the company's earnings release filed with the SEC on 2026-10-21 (Form 8-K).

What would change the picture for LRCX

These are the specific events and levels to watch. None of them is a prediction.

• An open-market purchase by an insider at Lam Research Corp. There has been none in 90 days; Form 4 filings would show one within two business days of the trade.
• Analyst ratings: the average score moved from 4.05 to 4.1 over three months. The scale runs from 5 for strong buy to 1 for strong sell. A run of downgrades after earnings usually shows up here first.
• Price levels: a close above $432.87 would be a new 52-week high, 66.0% above the latest close of $260.81. A close below $138.95 would be a new 52-week low, 46.7% below it.
• Growth: revenue rose 26.0% year over year in the quarter ending Jun 2026 (trend: steady). At a P/E of 45.3, a slowdown would matter more than at a lower multiple.
• New shares: dilution risk is low now. A new shelf registration (S-3) or a prospectus supplement (424B) for an offering would raise it.

LRCX history: what happened after similar moves

Since 2023, LRCX fell 16.0% or more in a month 4 times (separate episodes, not counting the current one). Three months later it was higher in 1 of 3 cases; the median change was -10.5%.

Past moves don't predict the next one; they show how volatile the stock has been.

Questions people also ask

What is LRCX's 52-week high and low?

Over the past year, LRCX closed as high as $432.87 and as low as $138.95. At $260.81 on Oct. 21, 2026, it is down 39.7% from the high and 87.7% above the low.

Are LRCX insiders buying or selling?

Insiders sold $40.5 million of LRCX on the open market in 90 days and bought none. Sales are often routine (taxes, diversification, pre-planned plans); purchases with their own money are the stronger signal.

Who is the largest shareholder of LRCX?

Among investment managers that file Form 13F, BlackRock Inc. reported the largest LRCX position ($57.5 billion). 3100 institutions reported holding LRCX for Q2 2026.

Does LRCX pay a dividend?

Yes: $1.04 per share over the last 12 months, about 0.4% at today's price.

Is Lam Research Corp profitable?

Yes. Lam Research Corp had $23.2 billion of revenue over the last 12 months. The net margin was 31.3%, and the P/E was 45.3.

Is Lam Research Corp issuing new shares?

Dilution risk reads low (10/100); the share count fell 1.1% in a year.

Dates to watch for LRCX

Insider trades can come any day: they must be filed on Form 4 within two business days.

Key terms on this page

P/E ratio

Price divided by the last 12 months of earnings per share. A P/E of 20 means investors pay $20 for each $1 of yearly profit. It is only defined when the company is profitable.

Price-to-sales

Market value divided by the last 12 months of revenue. Useful for companies with little or no profit, but it ignores margins.

Form 4

The SEC form a company's officers, directors and 10% owners must file within two business days of buying or selling its stock.

Open-market trade

A purchase or sale on the exchange at the market price, paid with the insider's own money (code P or S on Form 4), as opposed to option exercises, grants or gifts.

Form 13F

A quarterly SEC report listing the U.S. stock holdings of every investment manager with more than $100 million. It is due 45 days after each quarter ends, so it shows positions with a delay.

Dilution

When a company issues new shares, each existing share owns a smaller piece of the company. Common sources: stock offerings, convertible debt and large stock-based pay.

Form 8-K

The SEC form for material events between quarterly reports: earnings releases, deals, executive changes, stock offerings and similar news.

Where these numbers come from

Every number on this page is computed from the data when the page is refreshed (usually daily); nothing is typed in by hand. This is information, not investment advice.

• Price: daily closing prices through Oct. 21, 2026; changes use 5, 21 and 63 trading days; the 52-week range uses the last 252 closes.
• Insider trades: SEC Form 4 filings for the last 90 days count only open-market purchases (code P) and sales (code S). Option exercises, grants, gifts and filings with data errors are left out.
• Analyst ratings: counts of current ratings from 41 analysts, compared with three months ago.
• Earnings dates and estimates: a market-data calendar; reported vs expected EPS for the last 4 quarters.
• Valuation and growth: revenue, earnings, margins and share counts come from the company's SEC filings (XBRL data, latest quarter Jun 2026). P/E and price/sales use the latest close.
• Fund ownership: SEC Form 13F filings for Q2 2026.
• Dilution: share-count changes and offering-related SEC filings (shelf registrations, prospectus supplements, convertible notes) over two years, scored 0-100.
• History: 21-trading-day moves over about three years of daily closes, counted once per episode.